Accord Healthcare | WebDisclosure

Basculer en Français

11200	Companies
247896	Keywords
175680	Articles
133988	Press releases

Home
Companies
Accord Healthcare

BRIEF

published on 12/02/2025 at 08:10, 10 months 17 days ago

Accord Healthcare Launches Denosumab Biosimilar for Bone Health

Osteoporosis Bone Health Biosimilar Launch Accord Healthcare Denosumab
BRIEF

published on 12/02/2025 at 08:10, 10 months 17 days ago

Accord Healthcare lance un biosimilaire du dénosumab pour la santé osseuse

Ostéoporose Santé Osseuse Accord Healthcare Denosumab Lancement Des Biosimilaires
PRESS RELEASE

published on 12/02/2025 at 08:05, 10 months 17 days ago

Accord Healthcare Announces Launch of Denosumab∇ - Second Biosimilar in Bone Health
Accord Healthcare launches Osvyrti and Jubereq, biosimilar denosumab products for bone health, expanding patient access to cost-effective medicines. Approved by EMA, aiming to address osteoporosis burden

Biosimilar Bone Health Accord Healthcare Osvyrti Jubereq

Accesswire

Published on 10/19/2026 at 23:30, 3 hours 15 minutes ago

Quanta AI Completes Name Change
Published on 10/19/2026 at 23:20, 3 hours 25 minutes ago

CoTec Holdings Corp. Announces Investor Awareness Agreements
Published on 10/19/2026 at 23:00, 3 hours 45 minutes ago

Eskay Mining Corp. Announces Results of Annual Meeting
Published on 10/19/2026 at 22:50, 3 hours 55 minutes ago

Bluesky Digital Announces Termination of ChessGold Inc. Transaction and Management and Director Changes
Published on 10/19/2026 at 22:01, 4 hours 44 minutes ago

Unusual Machines Completes Acquisition of Upgrade Energy, Expanding U.S. Drone Battery Manufacturing

View all ACCESSWIRE

EQS Group

Published on 10/19/2026 at 22:16, 4 hours 29 minutes ago

EQS-Adhoc: Pentixapharm Holding AG: 2026 Earnings Guidance Raised; First-Patient Enrollment in PANDA Phase 3 Study Now Expected in the First Quarter of 2027
Published on 10/19/2026 at 21:22, 5 hours 22 minutes ago

EQS-Adhoc: Cantourage Group SE: Supervisory Board Resolves to Transition to IFRS Following First-Time Requirement to Prepare Consolidated Financial Statements
Published on 10/19/2026 at 19:00, 7 hours 45 minutes ago

PATRIMOINE ET COMMERCE : Déclaration des transactions sur actions propres (Hors contrat de liquidité) réalisées du 12/10/2026 au 16/10/2026
Published on 10/19/2026 at 18:05, 8 hours 40 minutes ago

Cognizant and Google Cloud Expand Alliance to Accelerate Agentic Enterprise Transformation
Published on 10/19/2026 at 17:45, 9 hours ago

VALBIOTIS SA: Valbiotis receives double “Best Pharma Product 2027” award for its ValbiotisPRO® Cholestérol and ValbiotisPRO® Santé Métabolique solutions

Les Echos

Published on 10/19/2026 at 19:00, 7 hours 45 minutes ago

COGRA : ASSEMBLÉE GÉNÉRALE MIXTE DU 16 OCTOBRE 2026 : Compte rendu et résultat des votes - Évolution de la gouvernance
Published on 10/19/2026 at 18:40, 8 hours 5 minutes ago

Reporting on share buyback transactions carried out between October 12 and October 13, 2026
Published on 10/19/2026 at 18:40, 8 hours 5 minutes ago

Déclaration de rachats d'actions effectués par la Compagnie de Saint-Gobain les 12 et 13 octobre 2026
Published on 10/19/2026 at 18:00, 8 hours 45 minutes ago

WHO Grants Emergency Use Listing for BIOFIRE® Global Fever Special Pathogens Panel, Expanding Access to Differential Diagnostics for the Ebola Response
Published on 10/19/2026 at 18:00, 8 hours 45 minutes ago

L’OMS accorde une autorisation d’utilisation d’urgence au test BIOFIRE® Global Fever Special Pathogens, élargissant l’accès au diagnostic différentiel face à l’épidémie d’Ebola

View all LES ECHOS COMFI WIRE